Evolus Total Assets 2016-2025 | EOLS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Evolus total assets from 2016 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Evolus total assets from 2016 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$230.8B
Boston Scientific (BSX)	$157.3B
Stryker (SYK)	$150.7B
EssilorLuxottica (ESLOY)	$147.8B
Medtronic (MDT)	$118.8B
Lonza Group Ag (LZAGY)	$49.6B
Haleon (HLN)	$44B
ResMed (RMD)	$43B
Agilent Technologies (A)	$34.6B
GE HealthCare Technologies (GEHC)	$34.3B
Terumo (TRUMY)	$27.7B
Koninklijke Philips (PHG)	$27.3B
Insulet (PODD)	$23.3B
Zimmer Biomet Holdings (ZBH)	$21.3B
Smith & Nephew SNATS (SNN)	$16.4B
Baxter (BAX)	$12.6B
Sunny Optical Technology (SNPTF)	$10.8B
Bio-Rad Laboratories (BIO)	$8.2B
Demant (WILYY)	$8.1B
Lantheus Holdings (LNTH)	$4B
Envista Holdings (NVST)	$3.6B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Perrigo (PRGO)	$3.4B
Prestige Consumer Healthcare (PBH)	$3.3B
ICU Medical (ICUI)	$3.2B
Haemonetics (HAE)	$2.7B
LeMaitre Vascular (LMAT)	$2.3B
Acuren (TIC)	$2.1B
QuidelOrtho (QDEL)	$1.9B
Curaleaf Holdings (CURLF)	$1.9B